Ironwood Pharmaceuticals Stock (NASDAQ: IRWD) stock price, news, charts, stock research, profile.
Open | $6.810 |
Close | $7.000 |
Volume / Avg. | 5.067M / 4.555M |
Day Range | 6.685 - 7.190 |
52 Wk Range | 6.210 - 15.700 |
Market Cap | $1.113B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 25.89% |
Days to Cover | 8.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.
Other companies in Ironwood Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and 4D Molecular Therapeutics (NASDAQ:FDMT).
The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Craig-Hallum on Friday, May 10, 2024. The analyst firm set a price target for 14.00 expecting IRWD to rise to within 12 months (a possible 100.00% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $7 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Ironwood Pharmaceuticals.
Ironwood Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.